CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 1,407,628 shares at an average $1.97 ($2,767,982)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 1,417,998 shares at an average $2.01 ($2,848,511)
- 4 Open-market sale 10% owner sold 671,536 shares at an average $2.10 ($1,411,083)
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Shareholder vote results · Other events
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 144 Insider Sale of Securities
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Grant or award Chief Development Officer acquired 937,080 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
Page 8 of 24 · 464 filings